Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Teleflex Incorporated Common Stock (NY:TFX)

118.36 -1.11 (-0.93%)
Official Closing Price Updated: 7:00 PM EDT, Jun 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Teleflex Incorporated Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Dow Pops As S&P 500, Nasdaq Stay On Sidelines
Stocks are seeing plenty of volatility today. 
Via Talk Markets
Topics Stocks Stocks / Equities
Gapping S&P500 stocks in Thursday's session
Stay updated with the S&P500 gap up and gap down stocks on Thursday. Get a glimpse of the market's movement during today's session. 
Via Chartmill
Teleflex Hits 52-Week Low On Plan To Split Into Two Companies, Reports Mixed Q4 Earnings
Teleflex to separate into two companies by mid-2026 and acquire Biotronik's Vascular Intervention unit for €760 million. CFO Thomas Powell to retire in April. 
Via Benzinga
Get insights into the top movers in the S&P500 index of Thursday's pre-market session.
Curious about the S&P500 stocks that are showing activity before the opening bell on Thursday? 
Via Chartmill
Teleflex (NYSE:TFX) Misses Q4 Sales Targets, Stock Drops
Medical technology company Teleflex (NYSE:TFX) missed Wall Street’s revenue expectations in Q4 CY2024 as sales rose 2.8% year on year to $795.4 million. Its non-GAAP profit of $3.89 per share was in... 
Via StockStory
Earnings Scheduled For February 27, 2025
Via Benzinga
How Is The Market Feeling About Teleflex?
Via Benzinga
How Is The Market Feeling About Teleflex?
Via Benzinga
Teleflex Announces Quarterly Dividend
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Reports Fourth Quarter and Full Year 2024 Financial Results
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Announces Planned Retirement of Thomas Powell As Chief Financial Officer
John Deren To Be Named Executive Vice President and Chief Financial Officer 
From Teleflex Incorporated
Via GlobeNewswire
P/E Ratio Insights for Teleflex
Via Benzinga
Where Teleflex Stands With Analysts
Via Benzinga
A Look Ahead: Teleflex's Earnings Forecast
Via Benzinga
Teleflex Announces Intent to Separate into Two Publicly Traded Companies
From Teleflex Incorporated
Via GlobeNewswire
Teleflex to Acquire BIOTRONIK’s Vascular Intervention Business
Acquisition will further advance Teleflex’s Interventional portfolio with a differentiated global suite of coronary vascular and peripheral vascular intervention devices 
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Earnings: What To Look For From TFX
Medical technology company Teleflex (NYSE:TFX) will be reporting earnings tomorrow before market open. Here’s what to look for. 
Via StockStory
Peering Into Teleflex's Recent Short Interest
Via Benzinga
Teleflex to Present at the Raymond James & Associates 46th Annual Institutional Investors Conference
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Announces Fourth Quarter 2024 Earnings Conference Call Information
From Teleflex Incorporated
Via GlobeNewswire
Teleflex awarded Short Term Central Venous Catheters contract from Vizient
Including market leading Arrow™ CVCs and Arterial Catheters 
From Teleflex Incorporated
Via GlobeNewswire
Teleflex to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From Teleflex Incorporated
Via GlobeNewswire
Glancy Prongay & Murray LLP Announces Investigation of Teleflex Incorporated (TFX)
From Glancy Prongay & Murray LLP
Via Business Wire
Teleflex to Present at the 36th Annual Piper Sandler Healthcare Conference
From Teleflex Incorporated
Via GlobeNewswire
Teleflex to Present at the Jefferies London Healthcare Conference
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Announces Quarterly Dividend
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Reports Third Quarter Financial Results and Full Year 2024 Outlook
From Teleflex Incorporated
Via GlobeNewswire
First Patient Enrolled in Teleflex’s Barrigel™ Rectal Spacer Trial for Post Radical Prostatectomy Radiation Therapy (PPRT)
Randomized, controlled study will be first in personalized spacing evidence to include patients who have a prostate cancer recurrence after prostatectomy. 
From Teleflex Incorporated
Via GlobeNewswire
New Data Presented at ASTRO 2024 Further Demonstrate the Safety and Efficacy of Barrigel™ Rectal Spacer, the First and Only Sculptable Hyaluronic Acid Rectal Spacer, in Patients Undergoing Radiation Therapy for Prostate Cancer(1-3)
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Announces Third Quarter 2024 Earnings Conference Call Information
From Teleflex Incorporated
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.